Aug 10, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2023-N-0743-0031
FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-N-0743, "Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines